{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T20:31:15Z","timestamp":1778704275248,"version":"3.51.4"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The advent of CAR-T cell therapy has changed the face of clinical care for relapsed and refractory pre-B-acute lymphocytic leukemia (B-ALL) and lymphoma. Although curative responses are reported, long-term cures remain below 50%. Different CAR T-cell leukemia targets appear to have different mechanisms of CAR-T escape. For CD22, therapeutic evasion is linked to down-modulation of the number CD22 proteins expressed on the extracellular aspect of the leukemia cell plasma membrane. Recently, pharmacologic agents known to induce cellular differentiation or epigenetic modification of leukemia have been shown to impact CD22 and CD19 expression levels on B-ALL, and thereby increase sensitivity to CAR-T mediated cytolysis. We explored the impact of epigenetic modifiers and differentiation agents on leukemia cell lines of B cell origin, as well as normal B cells. We confirmed the activity of bryostatin to increase CD22 expression on model cell lines. However, bryostatin does not change CD22 levels on normal B cells. Furthermore, bryostatin inhibited CAR-T mediated cytolysis of the Raji Burkitt lymphoma cell line. Bryostatin increased the cytolysis by CD22 CAR-T for B-ALL cell lines by at least three mechanisms: 1) the previously reported increase in CD22 target cell numbers on the cell surface, 2) the induction of NK ligands, and 3) the induction of ligands that sensitize leukemia cells to activated T cell antigen-non-specific killing. The opposite effect was seen for Burkitt lymphoma, which arises from a more mature B cell lineage. These findings should caution investigators against a universal application of agents shown to increase killing of leukemia target cells by CAR-T in a specific disease class, and highlights that activation of non-CAR-mediated killing by activated T cells may play a significant role in the control of disease. We have termed the killing of leukemia targets, by a set of cell-surface receptors that does not overlap with NK-like killing \u201cCTAK,\u201d CAR-T Cell antigen-non-specific killing.<\/jats:p>","DOI":"10.3389\/fimmu.2022.825364","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T06:38:54Z","timestamp":1644388734000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Bryostatin Activates CAR T-Cell Antigen-Non-Specific Killing (CTAK), and CAR-T NK-Like Killing for Pre-B ALL, While Blocking Cytolysis of a Burkitt Lymphoma Cell Line"],"prefix":"10.3389","volume":"13","author":[{"given":"Lingyan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eden","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Lamble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rimas J.","family":"Orentas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI133215","article-title":"Single Residue in CD28-Costimulated CAR-T Cells Limits Long-Term Persistence and Antitumor Durability","volume":"130","author":"Guedan","year":"2020","journal-title":"J Clin Invest"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4441","article-title":"CD22-Targeted CAR T Cells Induce Remission in B-ALL That Is Naive or Resistant to CD19-Targeted CAR Immunotherapy","volume":"24","author":"Fry","year":"2018","journal-title":"Nat Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817226","article-title":"Anti-BCMA CAR T-Cell Therapy Bb2121 in Relapsed or Refractory Multiple Myeloma","volume":"380","author":"Raje","year":"2019","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-793869","article-title":"Chimeric Antigen Receptor T-Cell Therapies for Multiple Myeloma","volume":"130","author":"Mikkilineni","year":"2017","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","first-page":"177ra38","DOI":"10.1126\/scitranslmed.3005930","article-title":"CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults With Chemotherapy-Refractory Acute Lymphoblastic Leukemia","volume":"5","author":"Brentjens","year":"2013","journal-title":"Sci Transl Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042718-041407","article-title":"Emerging Cellular Therapies for Cancer","volume":"37","author":"Guedan","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.03237","article-title":"Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia","volume":"38","author":"Frey","year":"2020","journal-title":"J Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1053\/bbmt.1998.v4.pm9763110","article-title":"CD20 Is a Molecular Target for Scfvfc:Zeta Receptor Redirected T Cells: Implications for Cellular Immunotherapy of CD20+ Malignancy","volume":"4","author":"Jensen","year":"1998","journal-title":"Biol Blood Marrow Transplant"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0246-1","article-title":"A Tandem CD19\/CD20 CAR Lentiviral Vector Drives on-Target and Off-Target Antigen Modulation in Leukemia Cell Lines","volume":"5","author":"Schneider","year":"2017","journal-title":"J Immunother Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2018.10.006","article-title":"Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22","volume":"11","author":"Qin","year":"2018","journal-title":"Mol Ther Oncolytics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"eabc6401","DOI":"10.1126\/scitranslmed.abc6401","article-title":"Trispecific CD19-CD20-CD22-Targeting duoCAR-T Cells Eliminate Antigen-Heterogeneous B Cell Tumors in Preclinical Models","volume":"13","author":"Schneider","year":"2021","journal-title":"Sci Transl Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0580-z","article-title":"Retention of CD19 Intron 2 Contributes to CART-19 Resistance in Leukemias With Subclonal Frameshift Mutations in CD19","volume":"34","author":"Asnani","year":"2020","journal-title":"Leukemia"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3784","article-title":"Modulation of Target Antigen Density Improves CAR T-Cell Functionality and Persistence","volume":"25","author":"Ramakrishna","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.049155","article-title":"The Cytotoxicity of Anti-CD22 Immunotoxin Is Enhanced by Bryostatin 1 in B-Cell Lymphomas Through CD22 Upregulation and PKC-\u03b2ii Depletion","volume":"97","author":"Biberacher","year":"2012","journal-title":"Haematologica"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-018-0053-7","article-title":"To Degrade or Not to Degrade: Mechanisms and Significance of Endocytic Recycling","volume":"19","author":"Cullen","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201601090","article-title":"The Endosomal Transcriptional Regulator RNF11 Integrates Degradation and Transport of EGFR","volume":"215","author":"Scharaw","year":"2016","journal-title":"J Cell Biol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1084\/jem.155.6.1823","article-title":"Lymphokine-Activated Killer Cell Phenomenon. Lysis of Natural Killer-Resistant Fresh Solid Tumor Cells by Interleukin 2-Activated Autologous Human Peripheral Blood Lymphocytes","volume":"155","author":"Grimm","year":"1982","journal-title":"J Exp Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1502193","article-title":"Efficient Culture of Human Naive and Memory B Cells for Use as Apcs","volume":"197","author":"Su","year":"2016","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-177139","article-title":"Engineering Human Hematopoietic Stem\/Progenitor Cells to Produce a Broadly Neutralizing Anti-HIV Antibody After In Vitro Maturation to Human B Lymphocytes","volume":"113","author":"Luo","year":"2009","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-438002","article-title":"Anti-CD22-Chimeric Antigen Receptors Targeting B-Cell Precursor Acute Lymphoblastic Leukemia","volume":"121","author":"Haso","year":"2013","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199510193331603","article-title":"Reconstitution of Cellular Immunity Against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones From the Donor","volume":"333","author":"Walter","year":"1995","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1038\/s41467-019-09982-5","article-title":"CUT&Tag for Efficient Epigenomic Profiling of Small Samples and Single Cells","volume":"10","author":"Kaya-Okur","year":"2019","journal-title":"Nat Commun"},{"key":"B23","article-title":"FastQC: A Quality Control Tool for High Throughput Sequence Data","author":"Andrews","year":"2010"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.1923","article-title":"Fast Gapped-Read Alignment With Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw257","article-title":"Deeptools2: A Next Generation Web Server for Deep-Sequencing Data Analysis","volume":"44","author":"Ram\u00edrez","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13072-019-0287-4","article-title":"Peak Calling by Sparse Enrichment Analysis for CUTnRUN Chromatin Profiling","volume":"12","author":"Meers","year":"2019","journal-title":"Epigenet Chromatin"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated Estimation of Fold Change and Dispersion for RNA-Seq Data With Deseq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)42143-0","article-title":"Differential Regulation of Protein Kinase C Isozymes by Bryostatin 1 and Phorbol 12-Myristate 13-Acetate in NIH 3T3 Fibroblasts","volume":"269","author":"Szallasi","year":"1994","journal-title":"J Biol Chem"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.61090","article-title":"Histone Deposition Pathways Determine the Chromatin Landscapes of H3.1 and H3.3 K27M Oncohistones","volume":"9","author":"Sarthy","year":"2020","journal-title":"Elife"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nri2020","article-title":"Intercellular Transfer of Cell-Surface Proteins Is Common and can Affect Many Stages of an Immune Response","volume":"7","author":"Davis","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0008-8749(83)90346-5","article-title":"Target Cell Specificity of Human Natural Killer (NK) Cells. I. Development of an NK-Resistant Subline of K562","volume":"76","author":"MacDougall","year":"1983","journal-title":"Cell Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112189","article-title":"Membrane Markers, Target Cell Specificity, and Sensitivity to Biological Response Modifiers Distinguish Human Natural Cytotoxic From Human Natural Killer Cells","volume":"76","author":"Rola-Pleszczynski","year":"1985","journal-title":"J Clin Invest"},{"key":"B33","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.121.5.1956","article-title":"Natural Killing and Antibody-Dependent Cellular Cytotoxicity Are Mediated by Different Mechanisms and by Different Cells","volume":"121","author":"Koren","year":"1978","journal-title":"J Immunol"},{"key":"B34","article-title":"First-In-Man Clinical Trial of CAR NK-92 Cells: Safety Test of CD33-CAR NK-92 Cells in Patients With Relapsed and Refractory Acute Myeloid Leukemia","volume":"8","author":"Tang","year":"2018","journal-title":"Am J Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19204","article-title":"A Phase I Trial of NK-92 Cells for Refractory Hematological Malignancies Relapsing After Autologous Hematopoietic Cell Transplantation Shows Safety and Evidence of Efficacy","volume":"8","author":"Williams","year":"2017","journal-title":"Oncotarget"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-018-0272-x","article-title":"Expression of Ligands for Activating Natural Killer Cell Receptors on Cell Lines Commonly Used to Assess Natural Killer Cell Function","volume":"20","author":"Tremblay-McLean","year":"2019","journal-title":"BMC Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1080\/14653240310002243","article-title":"Suppression of EBV Release From Irradiated B Lymphoblastoid Cell-Lines: Superior Activity of Ganciclovir Compared With Acyclovir","volume":"5","author":"Keever-Taylor","year":"2003","journal-title":"Cytotherapy"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e1009868","DOI":"10.1371\/journal.ppat.1009868","article-title":"NK Cells Eliminate Epstein-Barr Virus Bound to B Cells Through a Specific Antibody-Mediated Uptake","volume":"17","author":"Alari-Pahissa","year":"2021","journal-title":"PloS Pathog"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00428-20","article-title":"CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry Into T Cells","volume":"94","author":"Smith","year":"2020","journal-title":"J Virol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nri2056","article-title":"Siglecs and Their Roles in the Immune System","volume":"7","author":"Crocker","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M105446200","article-title":"CD22 Regulates B Cell Receptor-Mediated Signals via Two Domains That Independently Recruit Grb2 and SHP-1","volume":"276","author":"Otipoby","year":"2001","journal-title":"J Biol Chem"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsi.2018.09.068","article-title":"Macropinocytosis-Dependent Endocytosis of Japanese Flounder IgM+ B Cells and Its Regulation by CD22","volume":"84","author":"Li","year":"2019","journal-title":"Fish Shellfish Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900925","article-title":"Cullin 3 Is Crucial for Pro-B Cell Proliferation, Interacts With CD22, and Controls CD22 Internalization on B Cells","volume":"204","author":"Meyer","year":"2020","journal-title":"J Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25410","article-title":"Characterization of CD22 Expression in Acute Lymphoblastic Leukemia","volume":"62","author":"Shah","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16141","article-title":"Paclitaxel Synergizes With Exposure Time Adjusted CD22-Targeting Immunotoxins Against B-Cell Malignancies","volume":"8","author":"M\u00fcller","year":"2017","journal-title":"Oncotarget"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-0461","article-title":"Differential Cellular Internalization of Anti-CD19 and -CD22 Immunotoxins Results in Different Cytotoxic Activity","volume":"68","author":"Du","year":"2008","journal-title":"Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41375-020-0792-2","article-title":"CAR T-Cells That Target Acute B-Lineage Leukemia Irrespective of CD19 Expression","volume":"35","author":"Fousek","year":"2021","journal-title":"Leukemia"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2010.09.018","article-title":"Bryostatins: Biological Context and Biotechnological Prospects","volume":"21","author":"Trindade-Silva","year":"2010","journal-title":"Curr Opin Biotechnol"},{"key":"B49","article-title":"Bryostatin 1-Induced Hairy Cell Features on Chronic Lymphocytic Leukemia Cells In Vitro","volume":"21","author":"al-Katib","year":"1993","journal-title":"Exp Hematol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00258-20","article-title":"Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Suppresses Type I Interferon Signaling To Promote EBV Reactivation","volume":"94","author":"Liu","year":"2020","journal-title":"J Virol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/19.12.3080","article-title":"The Epstein-Barr Virus Lytic Program Is Controlled by the Co-Operative Functions of Two Transactivators","volume":"19","author":"Feederle","year":"2000","journal-title":"EMBO J"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3548","article-title":"Analysis of the Receptor-Ligand Interactions in the Natural Killer-Mediated Lysis of Freshly Isolated Myeloid or Lymphoblastic Leukemias: Evidence for the Involvement of the Poliovirus Receptor (CD155) and Nectin-2 (Cd112)","volume":"105","author":"Pende","year":"2005","journal-title":"Blood"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-21-0087","article-title":"Modulation of CD22 Protein Expression in Childhood Leukemia by Pervasive Splicing Aberrations: Implications for CD22-Directed Immunotherapies","author":"Zheng","year":"2021","journal-title":"Blood Cancer Discov"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.825364\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T09:46:10Z","timestamp":1674726370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.825364\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,9]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2022.825364"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.825364","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,9]]},"article-number":"825364"}}